Diabetes

Canadian company Sandoz is set to launch the very first generic semaglutide in 2026, making this costly treatment more accessible, possibly raising other issues.

More than 7,000 people with diabetes undergo a leg, foot or toe amputation every year—and the majority of those procedures could have been prevented, according to a new CIHI report.

How carefully did you read this recent Health Canada safety review?

The study also identifies factors associated with a clinically meaningful (≥ 10%) weight reduction at one year.

Get the info you need on this new product, part of our drug news roundup for September.

Two studies presented at the Alzheimer's Association's international conference highlight the beneficial effects of the drug liraglutide and a healthy diet on cognitive function and dementia risk reduction.

Do you find yourself hesitating when presented with a patient needing your help with wound care? If so, you are not alone. Susie Jin is eager to share how she gained confidence in treating wounds in community pharmacy practice.

These studies suggest that semaglutide and liraglutide are not linked with suicidality, but questions still remain.